Hero

Lumizyme/Myozyme

NA

APPROVED APPLICATIONS
MYOZYME®/LUMIZYME (alglucosidase alfa) is a lysosomal glycogen-specific enzyme indicated for use in patients with Pompe disease (GAA deficiency). Pompe disease is a rare, progressive and often fatal neuromuscular disease. MYOZYME replaces or supplements this enzyme in patients in whom is it is deficient.

Therapeutic Area

Enzyme Replacement Therapy

Acquisition Date

Jan 2011

Marketer

Sanofi